amlodipine has been researched along with Benign Neoplasms in 10 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients received amlodipine 5 mg daily for grade ≥ 2 bevacizumab-induced hypertension." | 7.78 | Treatment of bevacizumab-induced hypertension by amlodipine. ( Billemont, B; Blanchet, B; Cabanes, L; Camps, S; Coriat, R; Goldwasser, F; Knebelmann, B; Mir, O; Ropert, S, 2012) |
| " Patients received amlodipine 5 mg daily for grade ≥ 2 bevacizumab-induced hypertension." | 3.78 | Treatment of bevacizumab-induced hypertension by amlodipine. ( Billemont, B; Blanchet, B; Cabanes, L; Camps, S; Coriat, R; Goldwasser, F; Knebelmann, B; Mir, O; Ropert, S, 2012) |
| " This study aimed to investigate whether long-term use of valsartan increases cancer risk." | 1.72 | Cancer Risk of Angiotensin II Receptor Blocker Valsartan: A Population-based Study. ( Chan, TH; Tsoi, MF; Yung Cheung, BM, 2022) |
| "Verapamil was employed as a comparative agent." | 1.33 | Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. ( He, L; Ji, BS; Liu, GQ, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, TH | 1 |
| Tsoi, MF | 1 |
| Yung Cheung, BM | 1 |
| Tchernev, G | 1 |
| Li, C | 1 |
| Yao, H | 1 |
| Wang, H | 1 |
| Fang, JY | 1 |
| Xu, J | 1 |
| Shiozaki, A | 1 |
| Katsurahara, K | 1 |
| Otsuji, E | 1 |
| Franklin, PH | 1 |
| Banfor, PN | 1 |
| Tapang, P | 1 |
| Segreti, JA | 1 |
| Widomski, DL | 1 |
| Larson, KJ | 1 |
| Noonan, WT | 1 |
| Gintant, GA | 1 |
| Davidsen, SK | 1 |
| Albert, DH | 1 |
| Fryer, RM | 1 |
| Cox, BF | 1 |
| Mir, O | 1 |
| Coriat, R | 1 |
| Ropert, S | 1 |
| Cabanes, L | 1 |
| Blanchet, B | 1 |
| Camps, S | 1 |
| Billemont, B | 1 |
| Knebelmann, B | 1 |
| Goldwasser, F | 1 |
| Taranikanti, V | 1 |
| Alriyami, M | 1 |
| Banerjee, Y | 1 |
| Ji, BS | 1 |
| He, L | 1 |
| Liu, GQ | 1 |
| Goldstein, MR | 2 |
10 other studies available for amlodipine and Benign Neoplasms
| Article | Year |
|---|---|
Cancer Risk of Angiotensin II Receptor Blocker Valsartan: A Population-based Study.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Chann | 2022 |
NITROSAMINE CONTAMINATION WITHIN CARDIAC MULTIMEDICATION - SARTANS (VALSARTAN), CALCIUM CHANNEL BLOCKERS (AMLODIPINE AND NIFEDIPINE), AND ANTIARRHYTHMICS (PROPAFENONE) AS A SIGNIFICANT FACTOR IN THE DEVELOPMENT AND PROGRESSION OF MULTIPLE KERATINOCYTIC CA
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Anti-Arrhythmia Agents; Calcium Channel Blocker | 2023 |
Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity.
Topics: Amlodipine; Animals; Antineoplastic Agents; B7-H1 Antigen; Beclin-1; Calpain; Drug Repositioning; Ge | 2021 |
ASO Author Reflections: Amlodipine and Verapamil, Voltage-Gated Ca
Topics: Amlodipine; Humans; Neoplasms; Neoplastic Stem Cells; Stomach; Verapamil | 2021 |
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growt
Topics: Acrylates; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; A | 2009 |
Treatment of bevacizumab-induced hypertension by amlodipine.
Topics: Adult; Aged; Amlodipine; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antihypertensiv | 2012 |
Initial combination therapy for treatment of hypertension.
Topics: Amides; Amlodipine; Antihypertensive Agents; Drug Therapy, Combination; Fumarates; Humans; Hypertens | 2011 |
Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Topics: Amlodipine; Analysis of Variance; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1 | 2005 |
ASCOT-BPLA.
Topics: Amlodipine; Calcium Channel Blockers; Humans; Hypertension; Neoplasms; Randomized Controlled Trials | 2006 |
Does amlodipine increase cancer incidence?
Topics: Amlodipine; Calcium Channel Blockers; Coronary Artery Disease; Disease Progression; Humans; Incidenc | 2001 |